Back to UBS Group AG UBS Group AG

ANEBANEB
17 quarters

Position history for UBS Group AGUBS Group AG's holdings in ANEBULO PHARMACEUTICALS INC

UBS Group AG previously held 0 shares of ANEB (ANEBULO PHARMACEUTICALS INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$2,000

Total Shares Change

-234

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$0.36
0
2025-Q4
Increased
2,334
+960.9%
$2,3570.0%$0.98
13
2025-Q3
Increased
220
+139.1%
$5500.0%$2.42
12
2025-Q2
Increased
92
+9100.0%
$1320.0%$1.46
12
2025-Q1
Decreased
1
-96.0%
$10.0%$1.36
0
2024-Q4
Decreased
25
-96.7%
$420.0%$1.64
0
2024-Q3
New
763
-
$1,4730.0%$2.05
17
2024-Q2
Exited
0
-100.0%
$00.0%$2.73
0
2024-Q1
New
144
-
$4130.0%$2.87
17
2023-Q1
Exited
0
-100.0%
$00.0%$2.86
0
2022-Q4
Decreased
1,696
-39.0%
$4,1040.0%$2.42
0
2022-Q3
Decreased
2,781
-4.4%
$8,0000.0%$2.86
0
2022-Q2
Increased
2,909
+34.9%
$15,0000.0%$4.74
16
2022-Q1
Increased
2,156
+271.7%
$15,0000.0%$6.88
20
2021-Q4
Decreased
580
-31.6%
$4,0000.0%$6.15
0
2021-Q3
Increased
848
+262.4%
$6,0000.0%$6.80
17
2021-Q2
New
234
-
$2,0000.0%$6.58
17

Other major holders of ANEB: MORGAN STANLEY, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used